Benefits
Skin clarity in a 12-week multi-ingredient formula trial
In a placebo-controlled trial in 40 young adults with mild to moderate acne, a formula with 50 mg yellow dock root extract plus vitamins A, C and E, zinc, selenium, chromium, MSM, bromelain and three other herbs lowered lesion counts over 12 weeks more than placebo did. The maker funded it, and yellow dock's share of the effect cannot be separated.
Traditional use as a bitter and laxative herb
Yellow dock root has a long history as an astringent, laxative, mild tonic and bile-flow herb, and as a "blood cleanser", an idea that does not match modern physiology. No human study has measured its effect on digestion, bile flow or bowel regularity, so these uses rest on tradition rather than trial results.
Anthraquinone content of the root
Chemical studies of the root found anthraquinones and anthrones; one ethanol root extract held about 23 mg of anthraquinones per gram of extract, mainly chrysophanol, emodin and physcion. This is the compound family of stimulant laxatives such as senna, but how much a typical root supplement delivers, and whether it acts as a laxative in people, has not been measured.
Iron content and the iron tonic claim
One analysis of dried root found about 33 mg of iron per 100 g, along with phytate, a compound that can bind iron and reduce its absorption. No human study has measured whether yellow dock raises iron levels or blood counts, so its use as an iron tonic is traditional rather than demonstrated.
Liver cell and antioxidant findings from lab and animal work
Compounds isolated from the root reduced fat buildup in human liver-derived cells, and a fruit extract reduced oxidative damage in animals given a liver toxin. Root extracts also scavenged free radicals and lowered inflammatory signals in test-tube and cell studies. None of this has been tested in people taking the root.
Bone cell findings in a mouse study
A water extract of the plant reduced induced bone loss in mice and shifted the balance between bone-forming and bone-resorbing cells in culture. The study involved no human data, and bone outcomes have never been measured in people taking yellow dock.
Mechanism of action
Anthraquinones of the stimulant laxative type
The root's chrysophanol, emodin and physcion belong to the same chemical family as the active compounds in senna, a stimulant laxative that acts on the colon. This is the usual explanation for yellow dock's traditional laxative use, but the amount in commercial products and any effect on bowel function in people have not been measured.
Inflammatory signaling in cell studies
In mouse macrophage cells exposed to bacterial endotoxin, root extract fractions lowered nitric oxide and inflammatory cytokines, and a traditionally processed curly dock extract had a stronger effect than the plain extract. These are cell findings only.
Antioxidant activity in test tubes and animals
Root extract fractions scavenged free radicals in several test-tube assays, and a fruit extract raised liver glutathione and lowered lipid peroxidation in animals exposed to carbon tetrachloride. Whether oral root supplements change antioxidant status in people is unknown.
Clinical trials
Randomized, double-blind, placebo-controlled trial (NCT05879406) at a California dermatology research center, sponsored by the formula's maker, of a daily vitamin, mineral and botanical capsule containing 50 mg yellow dock root extract alongside burdock, dandelion and Oregon grape roots. (Ablon 2024, J Clin Aesthet Dermatol)
40 adults aged 18 to 40 with mild to moderate non-cystic acne (26 on the formula, 14 on placebo) for 84 days.
On the formula, inflammatory lesions fell from 21.4 to 10.4, non-inflammatory lesions from 35.0 to 19.5 and investigator grades by 0.9 grade, versus 20.8 to 17.9, 34.0 to 30.1 and 0.1 grade on placebo. The full text reports significant between-group differences for all three outcomes (p<0.0001) but does not name the test used; groups were small and unequal, and both used the same supplied cleanser, moisturizer and sunscreen. The formula also held vitamin A, zinc and other actives, so no effect can be attributed to yellow dock. It was well tolerated; mild itching was more common on the formula.
Single-patient case report with autopsy and scanning electron microscopy from the University of Barcelona. (Reig et al. 1990, Vet Hum Toxicol)
A 53-year-old man who ate Rumex crispus plant material.
He developed digestive symptoms, severe hypocalcemia, metabolic acidosis and acute liver failure, and died 72 hours after eating the plant despite treatment. Autopsy showed liver cell death and birefringent crystals in the liver and kidneys. The amount eaten is not stated in the abstract. One case, but it shows the plant can cause fatal poisoning.
Single-patient case report from a New Jersey hospital. (Latif et al. 2022, Eur J Case Rep Intern Med)
A woman in her late 30s or early 40s (the report gives both 38 and 41) with no prior medical history who drank a cleansing herbal tea bought online that contained yellow dock and burdock.
Red marks appeared on her skin 2 to 3 days after the tea; about a week after it her platelet count was 5 K/μl (her white cell count was also low), with bruises and pinpoint bleeding spots. After other causes were ruled out, doctors diagnosed immune thrombocytopenia and attributed it to the tea. One unit of platelets and 40 mg of dexamethasone raised her count to 143 K/μl by day 3, and it stayed normal at follow-up. One case involving two herbs, so the cause is not proven.
Test-tube antioxidant assays plus an animal study of a methanol extract of ripe yellow dock fruits, given alone or before the liver toxin carbon tetrachloride. (Maksimović et al. 2011, Phytother Res)
Laboratory animals; no human participants. The extract was made from fruits, not the root sold in supplements.
The extract was a strong free-radical scavenger in test tubes. In animals, pretreatment lowered liver lipid peroxidation and raised glutathione in a dose-dependent way after carbon tetrachloride, bringing antioxidant enzymes close to control values. Animal findings with a different plant part; not evidence of a liver effect in people.
Cell-culture work plus a mouse model of bone loss induced by RANKL injections, testing a water extract of Rumex crispus that contained emodin, chrysophanol and physcion. (Shim et al. 2017, BMC Complement Altern Med)
Mice and cultured bone cells; the authors state no human data were involved.
The extract reduced trabecular bone loss in the mice, increased mineralization by bone-forming cells and blocked formation of bone-resorbing cells in culture. These are preclinical results only.